125 related articles for article (PubMed ID: 2599909)
1. Radiobiological comparison of external beam irradiation and radioimmunotherapy in renal cell carcinoma xenografts.
Wessels BW; Vessella RL; Palme DF; Berkopec JM; Smith GK; Bradley EW
Int J Radiat Oncol Biol Phys; 1989 Dec; 17(6):1257-63. PubMed ID: 2599909
[TBL] [Abstract][Full Text] [Related]
2. Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts.
Ning S; Trisler K; Wessels BW; Knox SJ
Cancer; 1997 Dec; 80(12 Suppl):2519-28. PubMed ID: 9406705
[TBL] [Abstract][Full Text] [Related]
3. Comparison of systemic radiotherapy with I-131-labeled monoclonal antibody BW575/9 to external beam radiotherapy in human neuroblastoma xenografts.
Sautter-Bihl ML; Wessely R; Bihl H
Strahlenther Onkol; 1993 Oct; 169(10):595-600. PubMed ID: 8235984
[TBL] [Abstract][Full Text] [Related]
4. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
Buchsbaum DJ; Khazaeli MB; Mayo MS; Roberson PL
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
[TBL] [Abstract][Full Text] [Related]
5. Direct dose confirmation of quantitative autoradiography with micro-TLD measurements for radioimmunotherapy.
Griffith MH; Yorke ED; Wessels BW; DeNardo GL; Neacy WP
J Nucl Med; 1988 Nov; 29(11):1795-809. PubMed ID: 3263479
[TBL] [Abstract][Full Text] [Related]
6. Dosimetry and pharmacokinetics of monoclonal antibody A6H with human renal cell carcinoma xenografts: single dose study.
Palme DF; Berkopec JM; Wessels BW; Elson MK; Lange PH; Vessella RL
Int J Rad Appl Instrum B; 1991; 18(5):527-37. PubMed ID: 1917523
[TBL] [Abstract][Full Text] [Related]
7. The impact of tumor size on the efficacy of monoclonal antibody-targeted radiotherapy: studies using a nude mouse model with human renal cell carcinoma xenografts.
Chiou RK
J Urol; 1991 Jul; 146(1):232-7. PubMed ID: 2056596
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody-targeted radiotherapy of renal cell carcinoma using a nude mouse model.
Chiou RK; Vessella RL; Limas C; Shafer RB; Elson MK; Arfman EW; Lange PH
Cancer; 1988 May; 61(9):1766-75. PubMed ID: 2451555
[TBL] [Abstract][Full Text] [Related]
9. Comparison of radioimmunotherapy and external beam radiotherapy in colon cancer xenografts.
Buras RR; Wong JY; Kuhn JA; Beatty BG; Williams LE; Wanek PM; Beatty JD
Int J Radiat Oncol Biol Phys; 1993 Feb; 25(3):473-9. PubMed ID: 8436526
[TBL] [Abstract][Full Text] [Related]
10. Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re.
Brouwers AH; van Eerd JE; Frielink C; Oosterwijk E; Oyen WJ; Corstens FH; Boerman OC
J Nucl Med; 2004 Feb; 45(2):327-37. PubMed ID: 14960657
[TBL] [Abstract][Full Text] [Related]
11. Radioiodinated monoclonal antibodies in the imaging and treatment of human renal cell carcinoma xenografts in nude mice.
Vessella RL; Lange PH; Palme DF; Chiou RK; Elson MK; Wessels BW
Targeted Diagn Ther; 1988; 1():245-82. PubMed ID: 2979058
[No Abstract] [Full Text] [Related]
12. Targeting and therapy of human glioma xenografts in vivo utilizing radiolabeled antibodies.
Williams JA; Wessels BW; Edwards JA; Kopher KA; Wanek PM; Wharam MD; Order SE; Klein JL
Cancer Res; 1990 Feb; 50(3 Suppl):974s-979s. PubMed ID: 2404587
[TBL] [Abstract][Full Text] [Related]
13. Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with 131I-labelled monoclonal antibody E48 IgG.
Gerretsen M; Schrijvers AH; van Walsum M; Braakhuis BJ; Quak JJ; Meijer CJ; Snow GB; van Dongen GA
Br J Cancer; 1992 Sep; 66(3):496-502. PubMed ID: 1520586
[TBL] [Abstract][Full Text] [Related]
14. Calculated and TLD-based absorbed dose estimates for I-131-labeled 3F8 monoclonal antibody in a human neuroblastoma xenograft nude mouse model.
Ugur O; Scott AM; Kostakoglu L; Hui TE; Masterson ME; Febo R; Sgouros G; Rosa E; Mehta BM; Fisher DR
Nucl Med Biol; 1995 Jan; 22(1):87-93. PubMed ID: 7735175
[TBL] [Abstract][Full Text] [Related]
15. The effect of antibody protein dose of anti-renal cell carcinoma monoclonal antibodies in nude mice with renal cell carcinoma xenografts.
Kranenborg MH; Boerman OC; de Weijert MC; Oosterwijk-Wakka JC; Corstens FH; Oosterwijk E
Cancer; 1997 Dec; 80(12 Suppl):2390-7. PubMed ID: 9406688
[TBL] [Abstract][Full Text] [Related]
16. Comparison of 131I-labelled anti-episialin 139H2 with cisplatin, cyclophosphamide or external-beam radiation for anti-tumor efficacy in human ovarian cancer xenografts.
Molthoff CF; Pinedo HM; Schlüper HM; Rutgers DH; Boven E
Int J Cancer; 1992 Apr; 51(1):108-15. PubMed ID: 1563830
[TBL] [Abstract][Full Text] [Related]
17. Fractionated radioimmunotherapy of human colon carcinoma xenografts with 131I-labeled monoclonal antibody CC49.
Buchsbaum D; Khazaeli MB; Liu T; Bright S; Richardson K; Jones M; Meredith R
Cancer Res; 1995 Dec; 55(23 Suppl):5881s-5887s. PubMed ID: 7493364
[TBL] [Abstract][Full Text] [Related]
18. 131I radioimmunotherapy and fractionated external beam radiotherapy: comparative effectiveness in a human tumor xenograft.
Barendswaard EC; O'Donoghue JA; Larson SM; Tschmelitsch J; Welt S; Finn RD; Humm JL
J Nucl Med; 1999 Oct; 40(10):1764-8. PubMed ID: 10520720
[TBL] [Abstract][Full Text] [Related]
19. A comparison of 131I-labeled monoclonal antibody 17-1A treatment to external beam irradiation on the growth of LS174T human colon carcinoma xenografts.
Buchsbaum DJ; ten Haken RK; Heidorn DB; Lawrence TS; Glatfelter AA; Terry VH; Guilbault DM; Steplewski Z; Lichter AS
Int J Radiat Oncol Biol Phys; 1990 May; 18(5):1033-41. PubMed ID: 2347713
[TBL] [Abstract][Full Text] [Related]
20. Targeting of human glioma xenografts in vivo utilizing radiolabeled antibodies.
Williams JA; Wessels BW; Wharam MD; Order SE; Wanek PM; Poggenburg JK; Klein JL
Int J Radiat Oncol Biol Phys; 1990 Jun; 18(6):1367-75. PubMed ID: 2370186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
